FOXP3 mRNA expression levels peaking in stage III tumors and decreasing in stage IV tumors in both cohorts may be the result of high number and/or activity of FOXP3+ Tregs and other immune cells in the immune-reactive tumor microenvironment of stage III. The gene discussed is FOXP3; the disease is neoplasm.